Difference between revisions of "Part:BBa K1216007"
Line 18: | Line 18: | ||
<!-- --> | <!-- --> | ||
− | ===Characterization of the pLuxR=== | + | === Site directed mutagenesis of the BBa_R0062 pLuxR wild type promoter==== |
+ | |||
+ | Our goal was to achieve mutations in the luxbox of the pLuxR BBa_R0062 promoter to shift the dose response curve of the promoter depending on the OHHL (3-oxo-hexanoyl-l-homoserine-l-lactone) concentration. | ||
+ | <br> We did site directed mutagenisis of specific sites of the luxbox according to the results of the literature () | ||
+ | [[File:promoterscheme.jpg|400px|left|thumb|<b>Figure 1. Site of the directed mutagenesis in the luxbox.</b>As indicated you can see the mutations of the pLuxR variant compared to the wild type in red. The positions we mutated randomly are indicated in red-underlined]] | ||
+ | ===Characterization of the pLuxR variant dose response to OHHL using plate reader analysis and FACS single cell analysis=== |
Revision as of 18:17, 3 October 2013
Variant of the wild-type pLuxR promoter with lower sensitivity
BBa_K1216007 is a variant of the wild-type pLuxR promoter with a lowered sensitivity for LuxR-AHL.
Sequence and Features
Assembly Compatibility:
- 10COMPATIBLE WITH RFC[10]
- 12COMPATIBLE WITH RFC[12]
- 21COMPATIBLE WITH RFC[21]
- 23COMPATIBLE WITH RFC[23]
- 25COMPATIBLE WITH RFC[25]
- 1000COMPATIBLE WITH RFC[1000]
Site directed mutagenesis of the BBa_R0062 pLuxR wild type promoter=
Our goal was to achieve mutations in the luxbox of the pLuxR BBa_R0062 promoter to shift the dose response curve of the promoter depending on the OHHL (3-oxo-hexanoyl-l-homoserine-l-lactone) concentration.
We did site directed mutagenisis of specific sites of the luxbox according to the results of the literature ()